Eterna Therapeutics Inc (ERNA) — Cash Flow Reinvestment Rate
Eterna Therapeutics Inc (ERNA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $88.00 Million. Explore Eterna Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eterna Therapeutics Inc Cash Flow Reinvestment Rate (2009–2019)
Historical reinvestment intensity for Eterna Therapeutics Inc across 9 annual periods. Also explore Eterna Therapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Eterna Therapeutics Inc (2009–2019)
Year-by-year capital reinvestment analysis for Eterna Therapeutics Inc. For live market cap and broader valuation context, see ERNA company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.40x | $1.09 Million | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.61 Million | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $1.45 Million | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $840.00K | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $861.00K | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $1.23 Million | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $1.59 Million | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $1.32 Million | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $1.91 Million | $2.50 Million | $1.91 Million | — |